[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2016 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- 39.14%
YoY- -31.7%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 2,104,847 1,788,312 1,710,764 1,606,206 1,509,162 1,495,830 1,378,779 7.30%
PBT 46,609 58,280 53,198 67,948 89,005 87,726 59,990 -4.11%
Tax -17,323 -19,620 -20,299 -21,189 -20,462 -30,122 -24,496 -5.60%
NP 29,286 38,660 32,899 46,759 68,543 57,604 35,494 -3.15%
-
NP to SH 29,379 38,031 32,023 46,435 67,982 57,147 34,387 -2.58%
-
Tax Rate 37.17% 33.67% 38.16% 31.18% 22.99% 34.34% 40.83% -
Total Cost 2,075,561 1,749,652 1,677,865 1,559,447 1,440,619 1,438,226 1,343,285 7.51%
-
Net Worth 516,387 522,618 531,892 530,907 534,070 507,513 473,857 1.44%
Dividend
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Div 22,168 36,401 33,729 33,667 59,542 41,429 25,427 -2.25%
Div Payout % 75.46% 95.71% 105.33% 72.50% 87.59% 72.50% 73.95% -
Equity
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Net Worth 516,387 522,618 531,892 530,907 534,070 507,513 473,857 1.44%
NOSH 261,229 260,505 259,821 258,979 258,880 258,935 258,938 0.14%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 1.39% 2.16% 1.92% 2.91% 4.54% 3.85% 2.57% -
ROE 5.69% 7.28% 6.02% 8.75% 12.73% 11.26% 7.26% -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 807.07 687.79 659.36 620.21 582.96 577.69 532.47 7.17%
EPS 11.26 14.63 12.34 17.93 26.26 22.07 13.28 -2.71%
DPS 8.50 14.00 13.00 13.00 23.00 16.00 9.82 -2.37%
NAPS 1.98 2.01 2.05 2.05 2.063 1.96 1.83 1.32%
Adjusted Per Share Value based on latest NOSH - 259,146
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 146.04 124.08 118.70 111.44 104.71 103.79 95.67 7.30%
EPS 2.04 2.64 2.22 3.22 4.72 3.97 2.39 -2.60%
DPS 1.54 2.53 2.34 2.34 4.13 2.87 1.76 -2.19%
NAPS 0.3583 0.3626 0.369 0.3684 0.3706 0.3521 0.3288 1.44%
Price Multiplier on Financial Quarter End Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 -
Price 2.44 2.89 4.14 5.58 6.50 4.63 4.82 -
P/RPS 0.30 0.42 0.63 0.90 1.12 0.80 0.91 -16.87%
P/EPS 21.66 19.76 33.54 31.12 24.75 20.98 36.30 -8.24%
EY 4.62 5.06 2.98 3.21 4.04 4.77 2.76 8.96%
DY 3.48 4.84 3.14 2.33 3.54 3.46 2.04 9.30%
P/NAPS 1.23 1.44 2.02 2.72 3.15 2.36 2.63 -11.89%
Price Multiplier on Announcement Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 20/11/19 19/11/18 15/11/17 21/11/16 26/11/15 21/11/14 19/11/13 -
Price 2.21 3.09 3.82 5.70 6.50 4.45 4.72 -
P/RPS 0.27 0.45 0.58 0.92 1.12 0.77 0.89 -18.02%
P/EPS 19.62 21.13 30.95 31.79 24.75 20.16 35.54 -9.42%
EY 5.10 4.73 3.23 3.15 4.04 4.96 2.81 10.43%
DY 3.85 4.53 3.40 2.28 3.54 3.60 2.08 10.80%
P/NAPS 1.12 1.54 1.86 2.78 3.15 2.27 2.58 -12.97%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment